Archives of Gynecology and Obstetrics

, Volume 280, Issue 2, pp 183–186 | Cite as

Inhibin A levels and severity of preeclampsia

  • Vorapong Phupong
  • Krissada Paiwattananupant
  • Sittisak Honsawek
Original Article

Abstract

Objective

To evaluate the use of third trimester inhibin A levels to assess the severity of preeclampsia.

Materials and methods

Blood samples were taken from women diagnosed with mild and severe preeclampsia during the third trimester of pregnancy. Blood samples were collected in plain tubes, centrifuged and stored at −80°C until analyzed. All serum samples were measured for inhibin A levels by enzyme-linked immunosorbent assays.

Results

Inhibin A levels were greater in the severe (1,435.9 ± 603.2 pg/mL) than in the mild preeclampsia group (1,021.9 ± 438.8 pg/mL, P = 0.014).

Conclusion

Inhibin A levels rise with increasing severity of disease. However, there is considerable overlap of serum inhibin A levels in women with mild and severe preeclampsia. Inhibin A is therefore not a useful adjunct for the classification of preeclampsia.

Keywords

Inhibin A Preeclampsia Pregnancy Severity 

References

  1. 1.
    ACOG (2002) Diagnosis and management of preeclampsia and eclampsia, ACOG practical bulletin: clinical management guidelines for obstetrician-gynecologists Number 33. Obstet Gynecol 99:159–166. doi:10.1016/S0029-7844(01)01747-1 CrossRefGoogle Scholar
  2. 2.
    Arnholdt H, Meisel F, Fandrey K, Lohrs U (1991) Proliferation of villous trophoblast of the human placenta in normal and abnormal pregnancies. Virchows Arch B Cell Pathol Incl Mol Pathol 60:365–372. doi:10.1007/BF02899568 PubMedCrossRefGoogle Scholar
  3. 3.
    Birdsall M, Ledger W, Groome N, Abdalla H, Muttukrishna S (1997) Inhibin A and activin A in the first trimester of human pregnancy. J Clin Endocrinol Metab 82:1557–1560. doi:10.1210/jc.82.5.1557 PubMedCrossRefGoogle Scholar
  4. 4.
    Gratacos E, Casals E, Gomez O, Aibar C, Cararach V, Alonso PL, Fortuny A (2000) Inhibin A serum levels in proteinuric and nonproteinuric pregnancy-induced hypertension: evidence for placental involvement in gestational hypertension? Hypertens Pregnancy 19:315–321. doi:10.1081/PRG-100101993 PubMedCrossRefGoogle Scholar
  5. 5.
    Keelan JA, Taylor R, Schellenberg JC, Groome NP, Mitchell MD, North RA (2002) Serum activin A, inhibin A, and follistatin concentrations in preeclampsia or small for gestational age pregnancies. Obstet Gynecol 99:267–274. doi:10.1016/S0029-7844(01)01674-X PubMedCrossRefGoogle Scholar
  6. 6.
    Muttukrishna S (2004) Role of inhibin in normal and high-risk pregnancy. Semin Reprod Med 22:227–234. doi:10.1055/s-2004-831898 PubMedCrossRefGoogle Scholar
  7. 7.
    Muttukrishna S, George L, Fowler PA, Groome NP, Knight PG (1995) Measurement of serum concentrations of inhibin-A (alpha-beta A dimer) during human pregnancy. Clin Endocrinol (Oxf) 42:391–397. doi:10.1111/j.1365-2265.1995.tb02648.x CrossRefGoogle Scholar
  8. 8.
    Muttukrishna S, Knight PG, Groome NP, Redman CW, Ledger WL (1997) Activin A and inhibin A as possible endocrine markers for pre-eclampsia. Lancet 349:1285–1288. doi:10.1016/S0140-6736(96)09264-1 PubMedCrossRefGoogle Scholar
  9. 9.
    Muttukrishna S, North RA, Morris J, Schellenberg JC, Taylor RS, Asselin J, Ledger W, Groome N, Redman CW (2000) Serum inhibin A and activin A are elevated prior to the onset of pre-eclampsia. Hum Reprod 15:1640–1645. doi:10.1093/humrep/15.7.1640 PubMedCrossRefGoogle Scholar
  10. 10.
    Paiwattananupant K, Phupong V (2008) Serum inhibin A level in preeclampsia and normotensive pregnancy. Hypertens Pregnancy 27:337–343. doi:10.1080/10641950802020545 PubMedCrossRefGoogle Scholar
  11. 11.
    Phupong V, Dejthevaporn T, Tanawattanacharoen S, Manotaya S, Tannirandorn Y, Charoenvidhya D (2003) Predicting the risk of preeclampsia and small for gestational age infants by uterine artery Doppler in low-risk women. Arch Gynecol Obstet 268:158–161. doi:10.1007/s00404-002-0361-0 PubMedCrossRefGoogle Scholar
  12. 12.
    Phupong V, Hanprasertpong T, Honsawek S (2008) First trimester serum inhibin A in normal pregnant women. Arch Gynecol Obstet 277:307–310. doi:10.1007/s00404-007-0491-5 PubMedCrossRefGoogle Scholar
  13. 13.
    Redman CW (1991) Current topic: pre-eclampsia and the placenta. Placenta 12:301–308. doi:10.1016/0143-4004(91)90339-H PubMedCrossRefGoogle Scholar
  14. 14.
    Reis FM, D’Antona D, Petraglia F (2002) Predictive value of hormone measurements in maternal and fetal complications of pregnancy. Endocr Rev 23:230–257. doi:10.1210/er.23.2.230 PubMedCrossRefGoogle Scholar
  15. 15.
    Silver HM, Lambert-Messerlian GM, Reis FM, Diblasio AM, Petraglia F, Canick JA (2002) Mechanism of increased maternal serum total activin a and inhibin a in preeclampsia. J Soc Gynecol Investig 9:308–312. doi:10.1016/S1071-5576(02)00165-X PubMedCrossRefGoogle Scholar
  16. 16.
    Silver HM, Lambert-Messerlian GM, Star JA, Hogan J, Canick JA (1999) Comparison of maternal serum total activin A and inhibin A in normal, preeclamptic, and nonproteinuric gestationally hypertensive pregnancies. Am J Obstet Gynecol 180:1131–1137. doi:10.1016/S0002-9378(99)70606-X PubMedCrossRefGoogle Scholar
  17. 17.
    Zeeman GG, Alexander JM, McIntire DD, Byrd W, Leveno KJ (2002) Inhibin-A levels and severity of hypertensive disorders due to pregnancy. Obstet Gynecol 100:140–144. doi:10.1016/S0029-7844(02)02039-2 PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  • Vorapong Phupong
    • 1
  • Krissada Paiwattananupant
    • 1
  • Sittisak Honsawek
    • 2
  1. 1.Department of Obstetrics and Gynecology, Faculty of MedicineChulalongkorn UniversityBangkokThailand
  2. 2.Department of Biochemistry, Faculty of MedicineChulalongkorn UniversityBangkokThailand

Personalised recommendations